Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Código QR

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

Abstract Proton pump inhibitors (PPI) are an invaluable therapy option for acid related diseases; however, PPI therapy is also linked to a series of side effects in cirrhosis, such as microbiome alterations, spontaneous bacterial peritonitis and hepatic encephalopathy. Decision tools to balance bene...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Angela Horvath, Florian Rainer, Mina Bashir, Bettina Leber, Bianca Schmerboeck, Ingeborg Klymiuk, Andrea Groselj-Strele, Marija Durdevic, Daniel E. Freedberg, Julian A. Abrams, Peter Fickert, Philipp Stiegler, Vanessa Stadlbauer
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2019
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/55e5d506aa1545a8ba05694f4b1cb4d1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
por: Mattias Mandorfer, et al.
Publicado: (2014)

Proton pumping accompanies calcification in foraminifera
por: Takashi Toyofuku, et al.
Publicado: (2017)

Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective Study
por: Shanshan Sun, et al.
Publicado: (2021)

Gastric proton pump with two occluded K+ engineered with sodium pump-mimetic mutations
por: Kazuhiro Abe, et al.
Publicado: (2021)

A natural light-driven inward proton pump
por: Keiichi Inoue, et al.
Publicado: (2016)

The proton-pump inhibitor lansoprazole enhances amyloid beta production.
por: Nahuai Badiola, et al.
Publicado: (2013)

Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang XY, et al.
Publicado: (2021)

Voltage-gated optics and plasmonics enabled by solid-state proton pumping
por: Mantao Huang, et al.
Publicado: (2019)

Role of water and protein dynamics in proton pumping by respiratory complex I
por: Outi Haapanen, et al.
Publicado: (2017)

Delirium in the geriatric unit: proton-pump inhibitors and other risk factors
por: Otremba I, et al.
Publicado: (2016)

Locking loop movement in the ubiquinone pocket of complex I disengages the proton pumps
por: Alfredo Cabrera-Orefice, et al.
Publicado: (2018)

Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
por: Anne T Nies, et al.
Publicado: (2011)

Hyperacidification of Citrus fruits by a vacuolar proton-pumping P-ATPase complex
por: Pamela Strazzer, et al.
Publicado: (2019)

Redox-coupled proton pumping drives carbon concentration in the photosynthetic complex I
por: Jan M. Schuller, et al.
Publicado: (2020)

Effect of proton pump inhibitor use on Helicobacter pylori positivity and atrial fibrillation
por: Atay K, et al.
Publicado: (2015)

Rapid "breath-print" of liver cirrhosis by proton transfer reaction time-of-flight mass spectrometry. A pilot study.
por: Filomena Morisco, et al.
Publicado: (2013)

The light-driven proton pump proteorhodopsin enhances bacterial survival during tough times.
por: Edward F DeLong, et al.
Publicado: (2010)

SPECTRUM OF CULTURE POSITIVE HOSPITAL ACQUIRED PNEUMONIA IN PATIENTS RECEIVING PROTON PUMP INHIBITORS
por: Aaqib Jahangir Khan, et al.
Publicado: (2018)

Molecular mechanism of proton-coupled ligand translocation by the bacterial efflux pump EmrE.
por: Jakub Jurasz, et al.
Publicado: (2021)

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.
por: Lorena Maria Lima de Araújo, et al.
Publicado: (2021)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
por: Hyun-Jung Lee, et al.
Publicado: (2021)

The lateral distance between a proton pump and ATP synthase determines the ATP-synthesis rate
por: Johannes Sjöholm, et al.
Publicado: (2017)

Use of omeprazole, the proton pump inhibitor, as a potential therapy for the capecitabine-induced hand-foot syndrome
por: Shiori Hiromoto, et al.
Publicado: (2021)

Perceptions of patient-centered care among veterans with gastroesophageal reflux disease on proton pump inhibitor therapy
por: Salva Balbale, et al.
Publicado: (2018)

Microbial light-activatable proton pumps as neuronal inhibitors to functionally dissect neuronal networks in C. elegans.
por: Steven J Husson, et al.
Publicado: (2012)

Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
por: B. Hernández-Ochoa, et al.
Publicado: (2017)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
por: Furitsu Shimada, et al.
Publicado: (2021)

Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review with meta-analysis
por: Daniel Segna, et al.
Publicado: (2021)

Pharmacist-structured review of proton pump inhibitor utilisation in primary care: A non-randomised control study
por: Wong Su Li, et al.
Publicado: (2021)

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit
por: Myung Jin Song, et al.
Publicado: (2021)

Functional expression of the eukaryotic proton pump rhodopsin OmR2 in Escherichia coli and its photochemical characterization
por: Masuzu Kikuchi, et al.
Publicado: (2021)

No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study
por: Hakan Cetin, et al.
Publicado: (2020)

Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System
por: Liwei Wang, et al.
Publicado: (2017)

Characterization of a member of the CEACAM protein family as a novel marker of proton pump-rich ionocytes on the zebrafish epidermis.
por: Julien Kowalewski, et al.
Publicado: (2021)

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.
por: Imad M Tleyjeh, et al.
Publicado: (2012)

Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolation
por: F. Cordes, et al.
Publicado: (2021)

Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
por: Reuben Veysey-Smith, et al.
Publicado: (2021)

A physicians' wish list for the clinical application of intestinal metagenomics.
por: Ingeborg Klymiuk, et al.
Publicado: (2014)

Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer
por: Philip R. Cohen
Publicado: (2015)

Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: S. Tommasi, et al.
Publicado: (2017)